Morfini Massimo
Morfini Massimo
Associazione Italiana Centri Emofilici
Verified email at unifi.it
Title
Cited by
Cited by
Year
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ...
Journal of Thrombosis and Haemostasis 10 (4), 622-631, 2012
2892012
Consensus perspectives on prophylactic therapy for haemophilia: summary statement
E Berntorp, J Astermark, S Björkman, VS Blanchette, K Fischer, ...
Haemophilia 9, 1-4, 2003
2642003
The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development
J Astermark, E Berntorp, GC White, BL Kroner, MIBS Study Group
Haemophilia 7 (3), 267-272, 2001
2502001
European study on orthopaedic status of haemophilia patients with inhibitors
M Morfini, S Haya, G Tagariello, H Pollmann, M Quintana, B Siegmund, ...
Haemophilia 13 (5), 606-612, 2007
2072007
Human parvovirus B19 infection in hemophiliacs first infused with two high‐purity, virally attenuated factor Vlll concentrates
A Azzi, S Ciappi, K Zakvrzewska, M Morfini, G Mariani, PM Mannucci
American journal of hematology 39 (3), 228-230, 1992
2051992
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
C Leissinger, A Gringeri, B Antmen, E Berntorp, C Biasoli, S Carpenter, ...
New England Journal of Medicine 365 (18), 1684-1692, 2011
2012011
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
K Schimpf, PM Mannucci, W Kreutz, HH Bragkmann, C Auerswald, ...
New England Journal of Medicine 316 (15), 918-922, 1987
1861987
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey
MC Poon, R d'Oiron, M Von Depka, K Khair, C Negrier, A Karafoulidou, ...
Journal of Thrombosis and Haemostasis 2 (7), 1096-1103, 2004
1782004
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven®) in children vs. adults with haemophilia A
A Villar, S Aronis, M Morfini, E Santagostino, G Auerswald, HF Thomsen, ...
Haemophilia 10 (4), 352-359, 2004
1742004
Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
PW Collins, K Fischer, M Morfini, VS Blanchette, S Björkman, ...
Haemophilia 17 (1), 2-10, 2011
1722011
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
MM Cerinic, G Valentini, GG Sorano, S D'angelo, G Cuomo, L Fenu, ...
Seminars in arthritis and rheumatism 32 (5), 285-295, 2003
1632003
Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success
G Mariani, B Kroner, Immune Tolerance Study Group
haematologica 86 (11), 1186-1193, 2001
1622001
The transfusion-associated transmission of parvovirus B19
A Azzi, M Morfini, PM Mannucci
Transfusion medicine reviews 13 (3), 194-204, 1999
1611999
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ...
Blood 122 (11), 1954-1962, 2013
1522013
Monitoring the bioavailability of FEIBA with a thrombin generation assay
K Varadi, C Negrier, E Berntorp, J Astermark, JC Bordet, M Morfini, ...
Journal of Thrombosis and Haemostasis 1 (11), 2374-2380, 2003
1522003
Mortality and causes of death in Italian persons with haemophilia, 1990–2007
A Tagliaferri, GF Rivolta, A Iorio, E Oliovecchio, ME Mancuso, M Morfini, ...
Haemophilia 16 (3), 437-446, 2010
1402010
A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C
F Tradati, M Colombo, PM Mannucci, MG Rumi, C De Fazio, G Gamba, ...
Blood, The Journal of the American Society of Hematology 91 (4), 1173-1177, 1998
1401998
The design and analysis of half-life and recovery studies for factor VIII and factor IX
M Morfini, M Lee, A Messori
Thrombosis and haemostasis 66 (03), 384-386, 1991
1401991
Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month …
P Collins, A Faradji, M Morfini, MM Enriquez, L Schwartz
Journal of Thrombosis and Haemostasis 8 (1), 83-89, 2010
1392010
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
E Santagostino, C Negrier, R Klamroth, A Tiede, I Pabinger-Fasching, ...
Blood, The Journal of the American Society of Hematology 120 (12), 2405-2411, 2012
1342012
The system can't perform the operation now. Try again later.
Articles 1–20